[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. reported a Form 144 notice for the proposed sale of 21,531 common shares by a person holding founders' shares. The sale is scheduled to occur on 08/20/2025 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,000,014.59. The filer acquired these shares as founders' shares from the issuer on 12/27/2023. The filing states there were no securities sold in the past three months by the person for whose account the sale is proposed and includes the standard attestation that the signer does not possess undisclosed material adverse information.

Positive

• Compliance: The filer has submitted a Form 144, satisfying Rule 144 notice requirements for proposed insider sales.
• Transparent execution: Sale routed through a major broker (Morgan Stanley Smith Barney LLC), suggesting standard brokerage procedures.

Negative

• Insider sale planned: A holder of founders' shares intends to sell 21,531 shares, which could be viewed negatively by some investors despite small size relative to outstanding shares.

Insights

Securities Analyst

TL;DR: Small planned insider sale disclosed; procedural compliance observed, limited immediate market impact.

The Form 144 shows a proposed sale of 21,531 common shares valued at about $2.0 million, placed with a major broker. Relative to the issuer's stated outstanding shares (370,470,348), the block represents a de minimis portion of equity (well below 1%). The filer reports acquisition as founders' shares on 12/27/2023 and no prior sales in the last three months, which reduces the likelihood of an immediate signaling effect. The filing fulfills Rule 144 notice requirements and includes the standard attestation regarding material non-public information.

Corporate Governance Specialist

TL;DR: Disclosure is appropriate; monitoring insider activity advisable but no material governance red flags.

The notice documents a pre-public sale step required under securities laws and names a reputable broker, indicating standard execution channels. The origin of the shares as founders' shares is disclosed, and the absence of sales in the prior three months suggests this is not part of an ongoing heavy disposition. There is no mention of any 10b5-1 plan date, which could be relevant if the seller relies on an affirmative defense; the filing does state the attestation language about trading plans. From a governance perspective, this is routine disclosure rather than an event signaling governance issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21531	2000014.59	370470348	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			21531	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by CRWV disclose?

The filing discloses a proposed sale of 21,531 common shares valued at $2,000,014.59, scheduled for 08/20/2025, through Morgan Stanley Smith Barney LLC.

Who acquired the shares being sold and when?

The shares were acquired as founders' shares from the issuer on 12/27/2023.

Were any securities sold by this person in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

How large is the proposed sale relative to CoreWeave's outstanding shares?

The proposed 21,531 shares are small versus the reported 370,470,348 shares outstanding, representing well under 0.01% of outstanding shares.

Does the filing indicate the seller has undisclosed material information?

The filer signs the standard attestation representing that they do not know any material adverse information about the issuer that has not been publicly disclosed.